Table 1 Distribution of POU2F2 status in lung cancer according to clinicopathological characteristics
From: POU2F2 promotes the proliferation and motility of lung cancer cells by activating AGO1
Characteristics | Number of patients | POU2F2 expression | p value | |
|---|---|---|---|---|
Low (< median) | High (≥ median) | |||
Number | 50 | 25 | 25 | Â |
Sex | ||||
 Male | 24 | 11 | 13 | 0.571 |
 Female | 26 | 14 | 12 | |
Age (years) | ||||
 ≥ Mean (50) | 33 | 15 | 18 | 0.370 |
 < Mean (50) | 17 | 10 | 7 | |
Tumor size | ||||
 ≥ 3 (cm) | 30 | 11 | 19 | 0.021* |
 < 3 (cm) | 20 | 14 | 6 | |
Histology | ||||
 Adenocarcinoma | 27 | 13 | 14 | 0.777 |
 Squamous cell carcinoma | 23 | 12 | 11 | |
TNM stage | ||||
 I–II | 24 | 16 | 8 | 0.024* |
 III | 26 | 9 | 17 | |
Nodal status | ||||
 N0–N1 | 23 | 15 | 8 | 0.047* |
 N2–N3 | 27 | 10 | 17 | |
Differentiation | ||||
 Well-moderate | 23 | 13 | 10 | 0.395 |
 Poor | 27 | 12 | 15 | |